Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -30.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -1635 basis points from the comparable as-filed period.
Gross margin changed -969 basis points from the comparable as-filed period.
Gross profit changed -29.0% from the comparable as-filed period.
Inventory / revenue changed +6277 basis points from the comparable as-filed period.
Revenue changed -17.4% from the comparable as-filed period.
Research & development changed -28.4% from the comparable as-filed period.
Operating income changed -120.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Net income changed -249.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory changed +10.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.